Alpha, you are rightly entitled to your opinion. This company has secured "product rights, technology transfer, manufacturing rights and access to a product pipeline" (extracted from its homepage) and lists a number of Products as:
Recombinant Human Growth Hormone (SciTropin) Recombinant Interferons (SciFeron) Recombinant Human Insulin (SciLin)
Vaccines:
- Hepatitis B vaccine (Sci-B-Vac) - DAPT vaccine (SciDaPT) - DAPT/Hep B vaccine (SciDaPT/Hep B)
Today it announced the official lanch of the Hep B vaccine in Hong Kong. MMMmmmmm wonder where else in the world such a vaccine could be used? Musings aside, with nearly 9M shares traded and price up from 0.088 to close at 0.092 I don't see that 0.094 will pose any problems. My humble opinion only. Cheers
SIE Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
